Literature DB >> 9727981

Antimicrobial resistance. Is a major threat to public health.

R Wise, T Hart, O Cars, M Streulens, R Helmuth, P Huovinen, M Sprenger.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9727981      PMCID: PMC1113826          DOI: 10.1136/bmj.317.7159.609

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

1.  Molecular epidemiology of drug-resistant pneumococci: toward an international approach.

Authors:  P W Hermans; M Sluijter; S Dejsirilert; N Lemmens; K Elzenaar; A van Veen; W H Goessens; R de Groot
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

2.  Local surveillance of antimicrobial resistance. Synercid Resistance Surveillance Group.

Authors:  R Wise; J M Andrews
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

Review 3.  New strategies for antibacterial drug design.

Authors:  D J Knowles
Journal:  Trends Microbiol       Date:  1997-10       Impact factor: 17.079

Review 4.  The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally.

Authors:  T F O'Brien
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

5.  Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients.

Authors:  B Schwartz; D M Bell; J M Hughes
Journal:  JAMA       Date:  1997-09-17       Impact factor: 56.272

Review 6.  Multidrug-resistant Salmonella typhi: a worldwide epidemic.

Authors:  B Rowe; L R Ward; E J Threlfall
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

Review 7.  The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus.

Authors:  G A Ayliffe
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

  7 in total
  130 in total

1.  Acquired immunoparalysis in paediatric intensive care: prospective observational study.

Authors:  M Peters; A Petros; G Dixon; D Inwald; N Klein
Journal:  BMJ       Date:  1999-09-04

2.  Antibiotic resistance: the Bermuda experience.

Authors:  S Smith; R C Tilton
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

3.  Controversies in management: should general practitioners perform diagnostic tests on patients before prescribing antibiotics?

Authors:  H J Kolmos; P Little
Journal:  BMJ       Date:  1999-03-20

4.  Maggots are useful in treating infected or necrotic wounds.

Authors:  S Thomas; A Andrews; M Jones; J Church
Journal:  BMJ       Date:  1999-03-20

5.  Contributors to antibiotic resistance. Antibiotics should not be first treatment for acne.

Authors:  M J Cheesbrough
Journal:  BMJ       Date:  1999-03-06

6.  New-variant Creutzfeldt-Jacob disease.

Authors:  G Smith; R Charlton
Journal:  Br J Gen Pract       Date:  2000-08       Impact factor: 5.386

7.  Rationalised prescribing for community acquired pneumonia: a closed loop audit.

Authors:  H Clements; T Stephenson; V Gabriel; T Harrison; M Millar; A Smyth; W Tong; C J Linton
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

8.  National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents.

Authors:  L D Liebowitz; M Slabbert; A Huisamen
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

9.  Three-dimensional structure of the bacterial multidrug transporter EmrE shows it is an asymmetric homodimer.

Authors:  Iban Ubarretxena-Belandia; Joyce M Baldwin; Shimon Schuldiner; Christopher G Tate
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

10.  Respiratory tract infections in general practice: considerable differences in prescribing habits between general practitioners in Denmark and Spain.

Authors:  Lars Bjerrum; Albert Boada; Josep M Cots; Carlos Llor; Dolors Forés Garcia; Bente Gahrn-Hansen; Anders Munck
Journal:  Eur J Clin Pharmacol       Date:  2003-12-19       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.